Daisy Lio

713 total citations
16 papers, 541 citations indexed

About

Daisy Lio is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Daisy Lio has authored 16 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Immunology. Recurrent topics in Daisy Lio's work include Protein Kinase Regulation and GTPase Signaling (9 papers), Cell death mechanisms and regulation (4 papers) and Melanoma and MAPK Pathways (3 papers). Daisy Lio is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (9 papers), Cell death mechanisms and regulation (4 papers) and Melanoma and MAPK Pathways (3 papers). Daisy Lio collaborates with scholars based in Australia, United States and New Zealand. Daisy Lio's co-authors include Heung‐Chin Cheng, Janetta G. Culvenor, Peter E. Czabotar, Richard W. Birkinshaw, Su San Mok, Colin L. Masters, Andrew F. Hill, Cindy S. Luo, Peter M. Colman and Jianan Gong and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The EMBO Journal.

In The Last Decade

Daisy Lio

16 papers receiving 535 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daisy Lio Australia 10 365 111 99 85 62 16 541
Amos Bodner United States 7 328 0.9× 90 0.8× 50 0.5× 79 0.9× 23 0.4× 8 527
Shankar Varadarajan United Kingdom 16 467 1.3× 131 1.2× 20 0.2× 75 0.9× 92 1.5× 24 619
Qin Yu United States 13 393 1.1× 145 1.3× 36 0.4× 69 0.8× 138 2.2× 21 665
Ning Deng China 9 452 1.2× 69 0.6× 33 0.3× 82 1.0× 16 0.3× 11 681
Maayan Salton Israel 11 666 1.8× 66 0.6× 80 0.8× 40 0.5× 18 0.3× 19 766
Roland Hjerpe United Kingdom 13 844 2.3× 267 2.4× 91 0.9× 97 1.1× 215 3.5× 19 987
Joachim Bischof Germany 15 587 1.6× 210 1.9× 21 0.2× 42 0.5× 41 0.7× 33 826
Kejin Zhu United States 13 514 1.4× 84 0.8× 82 0.8× 59 0.7× 19 0.3× 22 729
Esther A. Suswam United States 13 494 1.4× 74 0.7× 130 1.3× 78 0.9× 38 0.6× 14 697
Frank Wu United States 10 466 1.3× 61 0.5× 21 0.2× 61 0.7× 27 0.4× 10 641

Countries citing papers authored by Daisy Lio

Since Specialization
Citations

This map shows the geographic impact of Daisy Lio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daisy Lio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daisy Lio more than expected).

Fields of papers citing papers by Daisy Lio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daisy Lio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daisy Lio. The network helps show where Daisy Lio may publish in the future.

Co-authorship network of co-authors of Daisy Lio

This figure shows the co-authorship network connecting the top 25 collaborators of Daisy Lio. A scholar is included among the top collaborators of Daisy Lio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daisy Lio. Daisy Lio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Iyer, Sweta, Agnes W. Wong, Ahmad Z. Wardak, et al.. (2024). A novel inhibitory BAK antibody enables assessment of non-activated BAK in cancer cells. Cell Death and Differentiation. 31(6). 711–721. 1 indexed citations
2.
Robin, A.Y., Michelle S. Miller, Sweta Iyer, et al.. (2022). Structure of the BAK-activating antibody 7D10 bound to BAK reveals an unexpected role for the α1-α2 loop in BAK activation. Cell Death and Differentiation. 29(9). 1757–1768. 6 indexed citations
3.
Birkinshaw, Richard W., Sweta Iyer, Daisy Lio, et al.. (2021). Structure of detergent-activated BAK dimers derived from the inert monomer. Molecular Cell. 81(10). 2123–2134.e5. 27 indexed citations
4.
Sandow, Jarrod J., Iris K. L. Tan, Shashank Masaldan, et al.. (2021). Dynamic reconfiguration of pro‐apoptotic BAK on membranes. The EMBO Journal. 40(20). e107237–e107237. 22 indexed citations
5.
Metcalfe, Riley D., Paul M. Nguyen, Craig J. Morton, et al.. (2020). The structure of the extracellular domains of human interleukin 11α receptor reveals mechanisms of cytokine engagement. Journal of Biological Chemistry. 295(24). 8285–8301. 46 indexed citations
6.
Birkinshaw, Richard W., Jianan Gong, Cindy S. Luo, et al.. (2019). Structures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mutations. Nature Communications. 10(1). 2385–2385. 172 indexed citations
7.
Liang, Lung‐Yu, Daisy Lio, Yee‐Foong Mok, et al.. (2018). The Roc‐COR tandem domain of leucine‐rich repeat kinase 2 forms dimers and exhibits conventional Ras‐like GTPase properties. Journal of Neurochemistry. 147(3). 409–428. 15 indexed citations
8.
Lim, Ya Chee, Bruno Catimel, Daisy Lio, et al.. (2017). Csk-homologous kinase (Chk) is an efficient inhibitor of Src-family kinases but a poor catalyst of phosphorylation of their C-terminal regulatory tyrosine. Cell Communication and Signaling. 15(1). 29–29. 12 indexed citations
9.
Catimel, Bruno, Daisy Lio, Ching‐Seng Ang, et al.. (2015). The C-terminal tail inhibitory phosphorylation sites of PTEN regulate its intrinsic catalytic activity and the kinetics of its binding to phosphatidylinositol-4,5-bisphosphate. Archives of Biochemistry and Biophysics. 587. 48–60. 9 indexed citations
10.
Baldwin, Graham S., Daisy Lio, Audrey Ferrand, et al.. (2013). Activation of Src family tyrosine kinases by ferric ions. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1844(3). 487–496. 2 indexed citations
11.
Ngoei, Kevin R. W., Bruno Catimel, Nicole L. Church, et al.. (2011). Characterization of a novel JNK (c-Jun N-terminal kinase) inhibitory peptide. Biochemical Journal. 434(3). 399–413. 26 indexed citations
14.
Crowhurst, Meredith O., Daisy Lio, Junjun Liu, et al.. (2007). Expression, generation, and purification of unphosphorylated and phospho-Ser-380/Thr-382/Thr-383 form of recombinant PTEN phosphatase. Protein Expression and Purification. 55(2). 334–342. 4 indexed citations
15.
Lio, Daisy, Su San Mok, Colin L. Masters, et al.. (2006). C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1. Human Molecular Genetics. 15(21). 3251–3262. 120 indexed citations
16.
Chong, Yuh‐Ping, Terrence D. Mulhern, Hong‐Jian Zhu, et al.. (2004). A Novel Non-catalytic Mechanism Employed by the C-terminal Src-homologous Kinase to Inhibit Src-family Kinase Activity. Journal of Biological Chemistry. 279(20). 20752–20766. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026